-
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Recommendation of "Buy" from Analysts
ソース: Buzz FX / 02 1 2025 09:56:14 America/New_York
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Shares of Corvus Pharmaceuticals, Inc.
Read more...